跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 329,602 条关于
“A Proliferation-Inducing Ligand”
全部
329,602
临床试验
279,155
药物
5,698
机构
4,018
资讯
40,731
9个月前
FDA Grants First Accelerated Approval for Novel IgA Nephropathy Treatment VOYXACT
2年前
Aurinia Pharmaceuticals Initiates Phase Ia Trial of AUR200 for Autoimmune Diseases
上个月
Aurinia Settles Patent Litigation with Teva, Securing U.S. Exclusivity for LUPKYNIS Until 2036
2年前
Vera Therapeutics to Discuss Atacicept's Expanded R&D for Immunological Diseases
2年前
Vera Therapeutics Completes Enrollment for Atacicept Phase 3 ORIGIN 3 Trial in IgAN
去年
RemeGen's Telitacicept Marketing Application for Generalized Myasthenia Gravis Accepted in China
9个月前
Vera Therapeutics Raises $300 Million in Public Offering to Advance Immunologic Disease Pipeline
去年
Vera Therapeutics Appoints Jason S. Carter as Chief Legal Officer
去年
Vera Therapeutics Receives FDA Breakthrough Therapy Designation for Atacicept in IgAN
去年
Jade Biosciences to Present Preclinical Data on JADE101 Anti-APRIL Antibody for IgA Nephropathy at European Renal Congress
第 1 页,共 4074 页
上一页
下一页